Brand Name: Cimzia
Generic Name: certolizumab pegol
Drug Class: Anti- TNFα
Manufacturer: UCB Group
FDA Approval date: April 2008
What is Cimzia?
Certolizumab is an injectable synthetic (man-made) protein that blocks the effects of tumor necrosis factor alpha (TNFα), therefore, reducing symptoms of arthritis (fever, pain, tenderness, and swelling of joints) and and symptoms of Crohn's disease (fever, abdominal pain, and diarrhea).
What does Cimzia treat?
Cimzia is used for treatment of severe Crohn’s disease and rheumatoid arthritis. It may be used alone or combined with methotrexate or other non-biological rheumatoid arthritis drugs. It has also been studied for treating psoriatic arthritis.
How effective is Cimzia?
What are interesting facts about Cimzia
How is Cimzia dosed?
What are the side effects of Cimzia?
Common: Respiratory tract infections, urinary tract infections and arthralgia (pain in joints), abdominal pain, diarrhea, intestinal obstruction
Serious: Tuberculosis, sepsis (bacteria in the blood), fungal infections, cancer, heart failure, reactivating hepatitis B, decrease in platelets and red blood cells
live attenuated vaccines
What is the cost of Cimzia?
Cimzia cost about $3,238 for one 200 mg/ml kit.